New method could improve manufacturing of gene-therapy drugs
Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.
Professor Anthony Sinskey, biologist, inventor, entrepreneur, and Center for Biomedical Innovation co-founder, dies at 84
Colleagues remember the longtime MIT professor as a supportive, energetic collaborator who seemed to know everyone at the Institute.
New leadership at MIT’s Center for Biomedical Innovation
Stacy Springs named executive director; Richard Braatz is associate faculty director.
SMART researchers enable early-stage detection of microbial contamination in cell therapy
Rapid and accurate analytical test method enhances the production of high-quality cell therapy products.
Study analyzes contamination in drug manufacturing plants
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.
MIT linQ welcomes IDEA² Global teams for 2018
Seven-month program includes 14 international groups, who are convening at the Institute to develop new biomedical technologies.
Spotlight on engineering staff
The School of Engineering gives its 2018 Infinite Mile Awards for exceptional service and support.
Pioneering a health care innovation ecosystem to better serve patients
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
MIT NEWDIGS Design Lab advances work on medical treatment financing strategies
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Spotlight on engineering staff
The School of Engineering gives its 2017 Infinite Mile Awards for exceptional service and support.
MIT NEWDIGS hosts design lab on new gene and oncology therapy financing models
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
MIT linQ names first IDEA^2 Global awardees
Twelve finalist teams pitched diverse new health care technologies at MIT.
How the U.S. can beat hepatitis C: Don’t buy the pills, buy the company
Pharma veteran and MIT visiting scientist Mark Trusheim advances a provocative solution to overcome treatment costs.
MIT Sloan takes interdisciplinary approach to managing food safety risks in China
Team announces collaboration with the Walmart Foundation.
MIT researchers author U.S. chapter of UNESCO Science Report
Stacy Springs and Shannon Stewart identify trends related to U.S. research and development funding and policy.